Affimed - Similar companies

We find the nearest competitors to any company through our proprietary AI and database of millions of companies


Biotechnology · Heidelberg, BW

Affimed (Nasdaq: AFMD) is a clinical-stage immuno-oncology company committed to giving patients back their innate ability to ... fight cancer. Affimed’s fit-for-purpose ROCK® platform produces diverse innate cell engagers for a multitude of cancers, and they share the critical ability to activate CD16A on innate immune cells. A growing set of clinical data has consistently demonstrated the safety of this method for killing tumors using the body’s own innate immune system. Most cancer therapies don’t take advantage of the full potential of the innate immune system to generate better responses. However, Affimed believes the power of the innate immune system is key to building a curative approach for all patients with cancer. Affimed’s ROCK®-generated innate cell engagers currently include two in clinical trials, with several additional engagers in pipeline: AFM13 has shown early signs of efficacy for patients with CD30+ lymphomas. AFM13 has broad clinical development potential as monotherapy and in combination with allogeneic Natural Killer cells of the innate immune system and other I-O therapies, such as PD-1 inhibitors. More information on the AFM13 registration-directed trial can be found here: AFM24 will bring Affimed’s innate immunity approach to solid tumors, beginning with a Phase 1 trial in 2020. For more information on the trial, visit: read more

Competitor Description Similarity